Abstract
Purpose
The study of adipokines in overweight women with early-onset (diagnosed before 20 weeks) gestational diabetes mellitus (GDM) could help to understand the ethiopathological mechanisms of this disorder. Our aim was to assess adipokine levels in overweight pregnant women with early-onset GDM compared to patients with standard-onset (diagnosed at 24–28 weeks) GDM and to glucose-tolerant women at the same gestational ages.
Methods
This nested case–control study included 133 overweight pregnant women: 33 with early-onset (diagnosed < 20 weeks) GDM; 40 with standard-onset (diagnosed ≥ 24 weeks) GDM and 60 glucose-tolerant (normal oral glucose tolerance tests < 20 and ≥ 24 weeks). Adiponectin, leptin, resistin, visfatin and ghrelin serum levels were measured by ELISA.
Results
Adiponectin serum levels were significantly lower in early-onset GDM women than in standard-onset GDM patients or controls matched for gestational age. Leptin serum levels were significantly higher in women with early-onset GDM than in controls. Women with early-onset GDM had lower adiponectin/leptin ratio than those with standard-onset GDM. There were no significant differences in resistin, ghrelin and visfatin serum levels among the participants.
Conclusions
Our results suggest that, compared to overweight glucose-tolerant women and patients with standard-onset GDM, overweight women with early-onset GDM have unbalanced adipokine levels, suggesting that they have a more inflammatory profile.
Similar content being viewed by others
References
Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O (2009) Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 10(2):194–203. https://doi.org/10.1111/j.1467-789X.2008.00541.x
Yuen L, Wong VW (2015) Gestational diabetes mellitus: challenges for different ethnic groups. World J Diabetes 6(8):1024–1032. https://doi.org/10.4239/wjd.v6.i8.1024
Gandhi P, Farrell T (2011) Gestational diabetes mellitus (GDM) screening in morbidly obese pregnant women. Eur J Obstet Gynecol Reprod Biol 159(2):329–332. https://doi.org/10.1016/j.ejogrb.2011.09.015
Immanuel J, Simmons D (2017) Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diabetes Rep 17(11):115. https://doi.org/10.1007/s11892-017-0943-7
WHO (2014) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract 103(3):341–363
Sweeting AN, Ross GP, Hyett J, Molyneaux L, Constantino M, Harding AJ, Wong J (2016) Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care 39(1):75–81. https://doi.org/10.2337/dc15-0433
Briana DD, Malamitsi-Puchner A (2009) Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 16(10):921–937. https://doi.org/10.1177/1933719109336614
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1):4–12
Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F (2017) The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Investig 40(8):859–866. https://doi.org/10.1007/s40618-017-0650-x
Marques-Vidal P, Bochud M, Paccaud F, Mooser V, Waeber G, Vollenweider P (2010) Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol (Oxf) 72(1):38–46. https://doi.org/10.1111/j.1365-2265.2009.03628.x
Gharibeh MY, Al Tawallbeh GM, Abboud MM, Radaideh A, Alhader AA, Khabour OF (2010) Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab 36(6 Pt 1):443–449. https://doi.org/10.1016/j.diabet.2010.05.003
Yadav A, Kataria MA, Saini V, Yadav A (2013) Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417:80–84. https://doi.org/10.1016/j.cca.2012.12.007
Lee YH, Magkos F, Mantzoros CS, Kang ES (2011) Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism 60(12):1664–1672. https://doi.org/10.1016/j.metabol.2011.04.008
Schwartz DR, Lazar MA (2011) Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 22(7):259–265. https://doi.org/10.1016/j.tem.2011.03.005
Vrachnis N, Belitsos P, Sifakis S, Dafopoulos K, Siristatidis C, Pappa KI, Iliodromiti Z (2012) Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol 2012:549748. https://doi.org/10.1155/2012/549748
Amini P, Wadden D, Cahill F, Randell E, Vasdev S, Chen X, Gulliver W, Zhang W, Zhang H, Yi Y, Sun G (2012) Serum acylated ghrelin is negatively correlated with the insulin resistance in the CODING study. PLoS One 7(9):e45657. https://doi.org/10.1371/journal.pone.0045657
Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 27(6):515–527. https://doi.org/10.1002/dmrr.1201
McGee KC, Harte AL, da Silva NF, Al-Daghri N, Creely SJ, Kusminski CM, Tripathi G, Levick PL, Khanolkar M, Evans M, Chittari MV, Patel V, Kumar S, McTernan PG (2011) Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFkappaB and JNK in human abdominal subcutaneous adipocytes. PLoS One 6(6):e20287. https://doi.org/10.1371/journal.pone.0020287
Guelfi KJ, Ong MJ, Li S, Wallman KE, Doherty DA, Fournier PA, Newnham JP, Keelan JA (2017) Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus. Metabolism 75:54–60. https://doi.org/10.1016/j.metabol.2017.08.003
Lain KY, Daftary AR, Ness RB, Roberts JM (2008) First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 69(3):407–411. https://doi.org/10.1111/j.1365-2265.2008.03198.x
Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhausl W (2001) Increased plasma leptin in gestational diabetes. Diabetologia 44(2):164–172. https://doi.org/10.1007/s001250051595
Chen D, Fang Q, Chai Y, Wang H, Huang H, Dong M (2007) Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol (Oxf) 67(2):208–211. https://doi.org/10.1111/j.1365-2265.2007.02862.x
Lopez-Tinoco C, Roca M, Fernandez-Deudero A, Garcia-Valero A, Bugatto F, Aguilar-Diosdado M, Bartha JL (2012) Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 58(1):14–19. https://doi.org/10.1016/j.cyto.2011.12.004
Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A (2007) Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 66(3):447–453. https://doi.org/10.1111/j.1365-2265.2007.02761.x
Skvarca A, Tomazic M, Krhin B, Blagus R, Janez A (2012) Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy. J Int Med Res 40(2):583–589. https://doi.org/10.1177/147323001204000220
Rezvan N, Hosseinzadeh-Attar MJ, Masoudkabir F, Moini A, Janani L, Mazaherioun M (2012) Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet 285(5):1257–1262. https://doi.org/10.1007/s00404-011-2156-7
Ma Y, Cheng Y, Wang J, Cheng H, Zhou S, Li X (2010) The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract 90(1):60–65. https://doi.org/10.1016/j.diabres.2010.06.010
Tham E, Liu J, Innis S, Thompson D, Gaylinn BD, Bogarin R, Haim A, Thorner MO, Chanoine JP (2009) Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase. Am J Physiol Endocrinol Metab 296(5):E1093–E1100. https://doi.org/10.1152/ajpendo.90866.2008
Genser B, Cooper PJ, Yazdanbakhsh M, Barreto ML, Rodrigues LC (2007) A guide to modern statistical analysis of immunological data. BMC Immunol 8:27. https://doi.org/10.1186/1471-2172-8-27
Cammu H, Dony N, Martens G, Colman R (2014) Common determinants of breech presentation at birth in singletons: a population-based study. Eur J Obstet Gynecol Reprod Biol 177:106–109. https://doi.org/10.1016/j.ejogrb.2014.04.008
Thagaard IN, Krebs L, Holm JC, Lange T, Larsen T, Christiansen M (2017) Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study. Clin Chem Lab Med 55(11):1805–1812. https://doi.org/10.1515/cclm-2017-0427
Maitland RA, Seed PT, Briley AL, Homsy M, Thomas S, Pasupathy D, Robson SC, Nelson SM, Sattar N, Poston L, consortium Ut (2014) Prediction of gestational diabetes in obese pregnant women from the UK Pregnancies Better Eating and Activity (UPBEAT) pilot trial. Diabet Med 31(8):963–970. https://doi.org/10.1111/dme.12482
Bhograj A, Suryanarayana KM, Nayak A, Murthy NS, Dharmalingam M, Kalra P (2016) Serum adiponectin levels in gestational diabetes mellitus. Indian J Endocrinol Metab 20(6):752–755. https://doi.org/10.4103/2230-8210.192909
Pala HG, Ozalp Y, Yener AS, Gerceklioglu G, Uysal S, Onvural A (2015) Adiponectin levels in gestational diabetes mellitus and in pregnant women without glucose intolerance. Adv Clin Exp Med 24(1):85–92. https://doi.org/10.17219/acem/38141
Zavalza-Gomez AB, Anaya-Prado R, Rincon-Sanchez AR, Mora-Martinez JM (2008) Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract 80(1):8–15. https://doi.org/10.1016/j.diabres.2007.12.012
Pendeloski KPT, Ono E, Torloni MR, Mattar R, Daher S (2017) Maternal obesity and inflammatory mediators: a controversial association. Am J Reprod Immunol. https://doi.org/10.1111/aji.12674
Gao XL, Yang HX, Zhao Y (2008) Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl) 121(8):701–705
Maple-Brown L, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R (2012) Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status. J Clin Endocrinol Metab 97(11):4148–4155. https://doi.org/10.1210/jc.2012-2290
Prentice AM, Jebb SA (2001) Beyond body mass index. Obes Rev 2(3):141–147
Ballesteros M, Simon I, Vendrell J, Ceperuelo-Mallafre V, Miralles RM, Albaiges G, Tinahones F, Megia A (2011) Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care 34(11):2418–2423. https://doi.org/10.2337/dc11-0788
Matuszek B, Burska A, Leszczynska-Gorzelak B, Donica H, Nowakowski A (2013) Comparative analysis of adiponectin isoform distribution in pregnant women with gestational diabetes mellitus and after delivery. Acta Obstet Gynecol Scand 92(8):951–959. https://doi.org/10.1111/aogs.12137
Acknowledgements
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2010-52547-5; 2011-14620-5) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 475500/2011-3).
Funding
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2010-52547-5; 2011-14620-5) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 475500/2011-3).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that there is no conflict of interest.
Ethical approval
The research protocol was approved by the university’s ethics committee.
Human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards
Informed consent
Written informed consent was obtained from all participants.
Rights and permissions
About this article
Cite this article
Lobo, T.F., Torloni, M.R., Mattar, R. et al. Adipokine levels in overweight women with early-onset gestational diabetes mellitus. J Endocrinol Invest 42, 149–156 (2019). https://doi.org/10.1007/s40618-018-0894-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0894-0